Abstract |
HLA-DR isotype is a MHC-II cell-surface receptor found on APCs and plays a key role in initiating immune responses. In severely immunocompromised patients with conditions like sepsis, the number of HLA-DR molecules expressed on leukocytes is considered to correlate with infectious complications and patients' probability of survival. The underlying regulatory mechanisms of HLA-DR expression remain largely unknown. One probable path to regulation is through microRNAs ( miRNAs), which have been implicated as regulatory elements of both innate and adaptive immune system development and function. In our study, flow cytometry-based high-throughput miRNA screening was performed in a stable HLA-DR-expressing human melanoma cell line, MelJuSo, for either up- or downregulating miRNAs of the surface HLA-DR expression. By the end of the screening, the top ten upregulators and top five downregulators were identified, and both the HLA-DR protein and mRNA regulations were further verified and validated. In-silico approaches were applied for functional miRNA- mRNA interaction prediction. The potential underlying gene regulations of different miRNAs were proposed. Our results promote the study of miRNA-mediated HLA-DR regulation under both physiological and pathological conditions, and may pave the way for potential clinical applications.
|
Authors | Maja Houseman, Melody Ying-Yu Huang, Markus Huber, Matthias Staiger, Lan Zhang, Anneliese Hoffmann, Christoph Lippuner, Frank Stüber |
Journal | European journal of immunology
(Eur J Immunol)
Vol. 52
Issue 9
Pg. 1452-1463
(09 2022)
ISSN: 1521-4141 [Electronic] Germany |
PMID | 35612261
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 The Authors. European Journal of Immunology published by Wiley-VCH GmbH. |
Chemical References |
- HLA-DR Antigens
- MicroRNAs
- RNA, Messenger
|
Topics |
- Flow Cytometry
- HLA-DR Antigens
(genetics, metabolism)
- Humans
- MicroRNAs
(genetics)
- RNA Interference
- RNA, Messenger
(genetics)
|